A mea culpa: I should’ve posted on this review by @biogerontology and coworkers a long time ago. It’s a steely-eyed, unflinching look at the (published) state of generative AI in preclinical drug discovery with the critical eye of a medicinal chemist.
pubs.acs.org/doi/10.1021/acs…
Indian Pharmacopoeia Commission (IPC) issued a drug safety alert about Meftal painkiller, stating that its constituent, mefenamic acid, can cause adverse reactions
Novel FDA Drug Approvals 3Q 2023 #medicine
It’s going to be a bumper year - 40 new drugs now approved by the FDA's Center for Drug Evaluation and Research (CDER)!
BREAKING NEWS
The Royal Swedish Academy of Sciences has decided to award the 2023 #NobelPrize in Chemistry to Moungi G. Bawendi, Louis E. Brus and Alexei I. Ekimov “for the discovery and synthesis of quantum dots.”
#Orbiton can identify, isolate and synthesis process-related impurities to support API process development. Timely delivery of complex API impurities at an affordable cost is a competitive edge to our clients across the globe.
Mail your queries at info@orbitonls.com
At #Orbiton, we strive to accelerate our clients success through innovative synthetic tools and technologies which save time and money.
Visit our website to learn about our technologies.
orbitonls.com
Growth is hard to achieve.
A typical company grew 2.8% per year in the decade before the pandemic.
What can your company do to improve the odds of success? Discover our 10 rules for growth: mck.co/3X2vJRu#growth#strategy
On this beautiful first day of 2023, the #Orbiton team wishes you a happy New Year full of joy, hope and success!
We thank you for your support in 2022, and we look forward to working with you all in 2023.